Akutes Nierenversagen – neue Erkenntnisse aus Diagnostik und Therapie

Schlüsselwörter

akutes Nierenversagen - Biomarker - Citrat-Antikoagulation - N-Acetylcystein - hämolytisch-urämisches Syndrom

Keywords

acute kidney injury - biomarkers - citrate anticoagulation - N-acetylcysteine - hemolytic-uremic syndrome

• Literatur

• 1 ACT-Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT). Circulation 2011; 124: 1250-1259
• 2 Bellomo R. Acute renal failure. Semin Respir Crit Care Med 2011; 32: 639-650
• 3 Chuasuwan A, Kellum J. Acute kidney injury and its management. Contrib Nephrol 2011; 171: 218-225
• 4 Dücker C, Dautel P, Wagner K et al. Klinische Symptomatik, Therapie und Verlauf stationär behandelter EHEC/EHEC-HUS Patienten. Dtsch Med Wochenschr 2011; 136: 1770-1776
• 5 Feldkamp T, Kribben A. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Minerva Med 2008; 99: 177-196
• 6 Frank C, Werber D, Cramer J et al. Epidemic profile of Shiga-toxin producing Escherichia coli O104:H4 Outbreak in Germany. N Engl J Med 2011; 365: 1771-1780
• 7 Kemper M. Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective. Pediatr Nephrol 2012; 27: 161-164
• 8 Lapeyraque A, Malina M, Fremeaux-Bacchi V et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011; 364: 2561-2563
• 9 Morigi M, Galbusera M, Gastoldi S et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011; 187: 172-180
• 10 Ostermann M, Dickie H, Barrett N. Renal replacement therapy in critically ill patients with acute kidney injury – when to start. Nephrol Dial Transplant doi: 2012;
• 11 Paragas N, Qiu A, Zhang Q et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nature Med 2011; 17: 216-222
• 12 Parikh C, Coca S, Thiessen-Philbrook H et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011; 22: 1748-1757
• 13 Saner F, Treckmann J, Geis A et al. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant doi: 2011 Nov 1. [Epub ahead of print]
• 14 Smith K, Wilker P, Reiter P et al. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J 2012; 31: 37-41
• 15 Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184
• 16 Wu M, Hsu Y, Bai C et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-analysis of randomized controlled trials. Am J Kidney Dis doi: 2012; Jan 4. [Epub ahead of print]